Author: Paul Shea

Mannkind Corporation (MNKD) Sinks As Biotech Has Rough Day

Mannkind Corporation (MNKD) Sinks As Biotech Has Rough Day

MannKind Corporation (NASDAQ:MNKD) stock was falling on Monday’s market after a report on the company suggested that the diabetes drug it has in development is “overhyped.” The report, which first came to light last Friday, was published by hedge fund Tourbillon Capital […]